Boston invests in tissue fixation and suturing
This article was originally published in Clinica
Executive Summary
In its fourth equity investment in two weeks, Boston Scientific has turned its attention to Onux Medical, a private company that designs and manufactures a new generation of tissue fixation and suturing devices. Boston, which paid an undisclosed amount into the company, also gets worldwide, exclusive distribution rights to Onux' flexible Touche technology.